Dalcetrapib does not prevent CETP-induced pre-β1-HDL formation, a potential marker of HDL functionality, in human plasma in vitro and in treated patients
Eric J. Niesor, Elisabeth von der Mark, Gregor Dernick, Cyrille Maugeais, David KallendVolume:
218
Year:
2011
Language:
english
DOI:
10.1016/j.atherosclerosis.2011.07.079
File:
PDF, 53 KB
english, 2011